[Kinetics of MDSC in Patients Treated Steroids-Ruxolitinib as the First Line Therapy for aGVHD].
Year: 2022
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Jing-Jing Yang, Bo Peng, Shu Fang, Yan Wei, Hao Wang, Ying-Xin Zhao, Kun Qian, Ya-Nan Wen, Dai-Hong Liu, Li-Ping Dou
Language: Chinese
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4210887104
